Published in Blood on July 26, 2016
European consensus conference on faecal microbiota transplantation in clinical practice. Gut (2017) 0.76
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature. Dig Dis Sci (2017) 0.76
The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood (2016) 0.75
Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol (2017) 0.75
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation. J Transl Med (2016) 0.75
The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly. Curr Treat Options Gastroenterol (2017) 0.75
Anticancer effects of the microbiome and its products. Nat Rev Microbiol (2017) 0.75
Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. Digestion (2017) 0.75
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity (2009) 9.01
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature (2013) 6.77
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 5.47
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med (2012) 3.17
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc Natl Acad Sci U S A (2013) 2.47
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood (2012) 2.30
Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood (2004) 2.20
How I treat refractory acute GVHD. Blood (2007) 2.05
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood (2014) 2.04
Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2005) 1.85
Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. Blood (2015) 1.74
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant (2014) 1.53
Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio (2012) 1.36
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biol Blood Marrow Transplant (2010) 1.36
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant (2015) 1.19
Fecal microbiota transplant after hematopoietic SCT: report of a successful case. Bone Marrow Transplant (2014) 0.95
Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplant (2015) 0.89
Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J Infect Chemother (2015) 0.88
Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol (2017) 1.40
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning. Biol Blood Marrow Transplant (2015) 0.94
Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis. Gut (2016) 0.79
ICOS(+) Foxp3(+) TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer (2016) 0.78
Draft Genome Sequence of Bifidobacterium aesculapii DSM 26737T, Isolated from Feces of Baby Common Marmoset. Genome Announc (2015) 0.76
Draft Genome Sequence of Coccoid Lactobacillus equigenerosi NRIC 0697T Isolated from the Gastrointestinal Tracts of Healthy Thoroughbreds. Genome Announc (2016) 0.75
Draft Genome Sequence of Bifidobacterium lemurum DSM 28807(T) Isolated from the Gastrointestinal Tracts of Ring-Tailed Lemurs (Lemur catta). Genome Announc (2017) 0.75
Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PLoS One (2017) 0.75
Draft Genome Sequence of Probiotic Lactobacillus acidophilus Strain L-55 Isolated from a Healthy Human Gut. Genome Announc (2016) 0.75
Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science (2017) 0.75
Gut microorganisms act together to exacerbate inflammation in spinal cords. Nature (2020) 0.75
Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation. Ann Hematol (2017) 0.75